Discontinued — last reported Q4 '24
Geographic · Net operating loss
Other foreign — Net operating loss
DexCom Other foreign — Net operating loss decreased by 100.0% to $0.00 in Q4 2024 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityModerate
First reportedQ4 2021
Last reportedQ4 2024
Rolls up toNet Operating Loss Carryforwards
How to read this metric
An increase in net operating loss suggests higher investment in market penetration or operational inefficiencies in these regions, while a decrease indicates improved profitability or reduced spending.
Detailed definition
This metric represents the net operating loss incurred within the company's 'Other Foreign' geographic segment, which en...
Peer comparison
Peers in the medical device industry often report similar geographic segment losses during early-stage international expansion phases before achieving economies of scale.
Metric ID:
dxcm_segment_other_foreign_net_operating_lossHistorical Data
4 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | |
|---|---|---|---|---|
| Value | $0.00 | $9.70M | $6.00M | $0.00 |
| QoQ Change | — | — | -38.1% | -100.0% |
| YoY Change | — | — | -38.1% | -100.0% |
Range$0.00 – $9.70M
Avg YoY Growth-69.1%
Median YoY Growth-69.1%
Current Streak2+ quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is DexCom's other foreign — net operating loss?
- DexCom (DXCM) reported other foreign — net operating loss of $0.00 in Q4 2024.
- What does other foreign — net operating loss mean?
- The net financial loss generated by the company's operations in secondary international markets.